The end of October is the deadline for the clinical part of the BLA, if Leronlimab gets BTD for the combo, then the manufacturing part also can be finished by the end of October, so the BLA can be completed by the end of October, if there is no BTD then in the beginning of December. NP keeps repeating, and we know, completing a BLA will change everything into CYDY, funding, uplist, partnership, etc. A month and a half or a month longer is not so much anymore. I believe that the NP has secured finances by the end of October and that it hopes to complete the BLA by then, he raised only as much as it needs to by the next step. Because in my opinion long-term financing will come with the BLA.